Inventor
Michael P. Vitek
Inventor
Cary, NC, US
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides24%
A61KPreparations for medical, dental or toiletry purposes21%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations18%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests7%
A01KAnimal husbandry4%
C12NMicroorganisms or enzymes3%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms3%
Y02ATechnologies for adaptation to climate change3%
A61BDiagnosis1%
PatentTitleYear
10,464,883Compounds and methods for the treatment of neurodegenerative diseases20199,815,884'ApoE peptide dimers and uses thereof'20179,809,640'ApoE peptide dimers and uses thereof'20179,730,979'Methods for decreasing set in inhibiting protein phosphatase 2A (PP2A) and/or increasing the activity of cyclin-dependent kinase 5 (CDK5) by an APOE peptide'20179,642,656'Intramedullary locking bone screw for fixing the metatarsophalangeal joint of the big toe in foot surgery'20178,993,833'Model of Alzheimer\'s Disease'20158,629,242'Methods of inhibiting calcineurin with ApoE analogs'20148,623,601'Methods of diagnosing cancer'20148,288,335'ApoE analogs and methods for their use'20128,288,336'Treatment of subarachnoid hemorrhage with ApoE analogs'20128,034,762'Treatment of subarachnoid hemorrhage with Apo E analogs'20117,947,645'APO E analogs and methods for their use'20117,432,061'Assays for measuring matrix metalloproteinase activities'20086,593,512'Transgenic mouse expressing human tau gene'20036,436,996'Modulation of nitric oxide production'20026,410,598'Compositions and methods for advanced glycosylation endproduct-mediated modulation of amyloidosis'20026,255,473'Presenilin-1 gene promoter'20015,935,927'Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts'19995,703,209'Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of .beta.-amyloid peptide'19975,693,478'Method of detecting amyloid precursor proteins'19975,656,477'Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of .beta.-amyloid peptide'19975,652,092'Amyloid precursor proteins and method of using same to assess agents which down-regulate formation of .beta.-amyloid peptide'1997Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1997Patents assigned to AMERICAN CYANAMID CO (4)· patent assignee history
1997–1999Based in East Norwich, NY, US· patent location history
2001–2015Patents assigned to UNIV DUKE (4)· patent assignee history
2001–2008Based in Apex, NC, US· patent location history
2003–2017Patents assigned to COGNOSCI INC (9)· patent assignee history
2011–2017Based in Cary, NC, US· patent location history
2012–2017Patents assigned to VITEK MICHAEL P (5)· patent assignee history
2014–2017Patents assigned to CHRISTENSEN DALE J (2)· patent assignee history
2017Based in Research Triangle Park, NC, US· patent location history
2019Based in Efland, NC, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| COGNOSCI INC | 9 | 2003–2017 |
| VITEK MICHAEL Pself | 5 | 2012–2017 |
| AMERICAN CYANAMID CO | 4 | 1997 |
| UNIV DUKE | 4 | 2001–2015 |
| CHRISTENSEN DALE J | 2 | 2014–2017 |
Locations
| Location | Patents | Span |
|---|---|---|
| Cary, NC, US | 8 | 2011–2017 |
| Apex, NC, US | 5 | 2001–2008 |
| East Norwich, New York, US | 5 | 1997–1999 |
| Research Triangle Park, NC, US | 2 | 2017 |
| Efland, NC, US | 1 | 2019 |